adding < addition < additional

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000009 (2008)	Misato Hashizume [Japon] ; Masahiko Mihara [Japon]	Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
000016 (2009)	Mao Mao An [République populaire de Chine] ; Zui Zou [République populaire de Chine] ; Hui Shen [République populaire de Chine] ; Jun Dong Zhang [République populaire de Chine] ; Yong Bing Cao [République populaire de Chine] ; Yuan Ying Jiang [République populaire de Chine]	The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials
000023 (2009)	Misato Hashizume [Japon] ; Yasushi Uchiyama [Japon] ; Naoto Horai [Japon] ; Naohisa Tomosugi [Japon] ; Masahiko Mihara [Japon]	Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
000029 (2011)	Satoru Shinriki [Japon] ; Hirofumi Jono [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Tomoko Ota [Japon] ; Takanao Sueyoshi [Japon] ; Yuichi Oike [Japon] ; Mutsuko Ibusuki [Japon] ; Akimitsu Hiraki [Japon] ; Hideki Nakayama [Japon] ; Masanori Shinohara [Japon] ; Yukio Ando [Japon]	Interleukin‐6 signalling regulates vascular endothelial growth factor‐C synthesis and lymphangiogenesis in human oral squamous cell carcinoma
000035 (2013)	T. Witte [Allemagne]	Methotrexat als Kombinationspartner bei TNF-Inhibitoren und Tocilizumab
000043 (2009)	Kazuko Matsumoto [Japon] ; Takao Nagashima [Japon] ; Shino Takatori [Japon] ; Yuta Kawahara [Japon] ; Masaki Yagi [Japon] ; Masahiro Iwamoto [Japon] ; Hitoaki Okazaki [Japon] ; Seiji Minota [Japon]	Glucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumab
000044 (2010)	Yoh Arita [Japon] ; Yasushi Sakata [Japon] ; Takao Sudo [Japon] ; Tetsuo Maeda [Japon] ; Ken Matsuoka [Japon] ; Keito Tamai [Japon] ; Kaori Higuchi [Japon] ; Wataru Shioyama [Japon] ; Yoshikazu Nakaoka [Japon] ; Yuzuru Kanakura [Japon] ; Keiko Yamauchi-Takihara [Japon]	The efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman’s disease
000052 (2009)	Miho Suzuki [Japon] ; Misato Hashizume [Japon] ; Hiroto Yoshida [Japon] ; Masahiko Mihara [Japon]	Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule
000066 (2013)	Kanae Tani [Japon] ; Risa Takayanagi [Japon] ; Haruko Yokoyama [Japon] ; Yasuhiko Yamada [Japon]	Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
000104 (2012)	Anshuman P. Malaviya [Royaume-Uni, Niger] ; Andrew J. K. Östör [Royaume-Uni]	Rheumatoid arthritis and the era of biologic therapy
000146 (2010)	G. Horneff [Allemagne]	Juvenile Arthritiden
000149 (2010)	J. Wollenhaupt [Allemagne] ; K. Krüger [Allemagne]	Nicht-TNF-Biologika in der Therapiestrategie bei rheumatoider Arthritis
000155 (2009)	Misato Hashizume [Japon] ; Naohiko Hayakawa [Japon] ; Miho Suzuki [Japon] ; Masahiko Mihara [Japon]	IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system
000173 (2013)	Nam Trung Nguyen [Japon, Viêt Nam] ; Taisuke Nakahama [Japon] ; Tadamitsu Kishimoto [Japon]	Aryl hydrocarbon receptor and experimental autoimmune arthritis
000176 (2010)	I. H. Tarner [Allemagne] ; U. Müller-Ladner [Allemagne] ; C. Hamm [Allemagne]	Biologika und kardiovaskuläres Risiko
000178 (2010)	G. Dückers [Allemagne] ; T. Niehues [Allemagne]	Die Bedeutung von Biologika bei der Therapie der SoJIA (Morbus Still)
000267 (2013)	S. Goldacker [Allemagne] ; A. M. Gause [Allemagne] ; K. Warnatz [Allemagne]	Impfung bei erwachsenen Patienten mit chronisch entzündlichen rheumatischen Erkrankungen
000279 (2010)	Arnd Heiligenhaus [Allemagne] ; Stephan Thurau [Allemagne] ; Maren Hennig [Allemagne] ; Rafael S. Grajewski [Allemagne] ; Gerhild Wildner [Allemagne]	Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease
000294 (2013)	Shunsei Hirohata [Japon] ; Tetsuya Tomita [Japon] ; Hideki Yoshikawa [Japon] ; Masahisa Kyogoku [Japon]	TNF inhibitors induce discoid fibrosis in the sublining layers of the synovium with degeneration of synoviocytes in rheumatoid arthritis
000299 (2011)	Nada Kherbeck [France] ; Mathieu C. Tamby [France] ; Guillaume Bussone [France] ; Hanadi Dib [France] ; Frederic Perros [France] ; Marc Humbert [France] ; Luc Mouthon [France]	The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension
000308 (2013)	M. Vis [Pays-Bas] ; M. Güler-Yüksel [Pays-Bas] ; W. F. Lems [Pays-Bas]	Can bone loss in rheumatoid arthritis be prevented?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "addition" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "addition" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    addition
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021